Last updated: 24 January 2018 at 5:21am EST

S.A. Ipsen, Net Worth




The estimated Net Worth of S.A. Ipsen, is at least 41.1 百万$ dollars as of 10 October 2017. S Ipsen owns over 20,000 units of Rhythm Pharmaceuticals stock worth over 41,080,112$ and over the last 7 years S sold RYTM stock worth over 0$.

S Ipsen RYTM stock SEC Form 4 insiders trading

S has made over 1 trades of the Rhythm Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently S bought 20,000 units of RYTM stock worth 340,000$ on 10 October 2017.

The largest trade S's ever made was buying 20,000 units of Rhythm Pharmaceuticals stock on 10 October 2017 worth over 340,000$. On average, S trades about 20,000 units every 0 days since 2017. As of 10 October 2017 S still owns at least 833,099 units of Rhythm Pharmaceuticals stock.

You can see the complete history of S Ipsen stock trades at the bottom of the page.



What's S Ipsen's mailing address?

S's mailing address filed with the SEC is 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France.

Insiders trading at Rhythm Pharmaceuticals

Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over 83,445,563$ worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth 106,961,700$ . The most active insiders traders include Forest BaskettScott D SandellPeter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of 3,358,405$. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth 77,963$.



What does Rhythm Pharmaceuticals do?

rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.



Complete history of S Ipsen stock trades at Rhythm Pharmaceuticals

インサイダー
取引
取引
合計金額
S.A. Ipsen,
10%所有者
購入する 340,000$
10 Oct 2017


Rhythm Pharmaceuticals executives and stock owners

Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: